Seattle Children’s Opens First CAR T-Cell Immunotherapy Trial in the U.S. for Children and Young Adults With Leukemia that Targets CD22 and CD19 Proteins Simultaneously By launching a bilateral attack on cancer cells, researchers hope to ultimately increase patients’ long-term remission